Clarendon Fund Managers
Clarendon Fund Managers Limited is a venture capital firm based in Belfast, Northern Ireland, that focuses on investing in small and medium enterprises. Established in 2001, the firm manages £42.5 million in regional venture capital funds, including a significant £30 million Co-Investment Fund. Clarendon Fund Managers typically invests between £20,000 and £250,000 in various sectors, particularly in manufacturing and tradable services, while favoring companies located in Northern Ireland. The firm is known for its collaborative approach, often engaging in co-investments alongside business angels and private investors. Since its inception, it has invested in over 60 companies, with a typical exit strategy planned within five to seven years.
See.Sense creates award-winning products that make riders safer on the road, and technology that generates the data cities need to build better transport infrastructure. Our products are used by more than 50,000 cyclists worldwide and we're the official bike light and ride insights suppliers to both British Cycling and Cycling Ireland. The data our patented products gather is unique - seeing us work with leading smart cities around the world, to improve cycling infrastructure, reduce congestion and improve mobility in cities. We've won multiple business, design and innovation awards, and design and manufacture our technology products in Northern Ireland.
See.Sense creates award-winning products that make riders safer on the road, and technology that generates the data cities need to build better transport infrastructure. Our products are used by more than 50,000 cyclists worldwide and we're the official bike light and ride insights suppliers to both British Cycling and Cycling Ireland. The data our patented products gather is unique - seeing us work with leading smart cities around the world, to improve cycling infrastructure, reduce congestion and improve mobility in cities. We've won multiple business, design and innovation awards, and design and manufacture our technology products in Northern Ireland.
Non Equity Assistance in 2014
Autism Biotech is a company based in Belfast, Northern Ireland, focused on developing a biochemical test for the early and reliable diagnosis of autism spectrum disorder. Their product, ASDtect, utilizes peptide biomarkers protected by two granted patents to facilitate the detection of autism from a simple blood sample. This innovative approach aims to address a significant and largely untapped market, enhancing the ability of healthcare professionals to diagnose and subsequently treat individuals with autism. Currently, Autism Biotech is conducting clinical trials to ensure the efficacy of ASDtect, with plans to make the diagnostic test available in the near future.
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.
Kelsius is a provider of automation technology focused on product safety and compliance within the food services and healthcare sectors. Founded in 2003 and headquartered in Donegal, Ireland, the company specializes in wireless temperature monitoring systems and a digital HACCP Management system. These technologies enhance product safety, ensure adherence to regulatory standards, and help optimize related costs. By reducing product wastage due to refrigerator malfunctions and improving food quality, Kelsius empowers clients to manage food safety more effectively through automated processes, ultimately leading to significant cost savings and increased labor efficiency.
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.